Premium
O1–06–05: The novel BACE inhibitor MK‐8931 dramatically lowers CSF beta‐amyloid in patients with mild‐to‐moderate Alzheimer's disease
Author(s) -
Forman Mark,
Kleijn HuubJan,
Dockendorf Marissa,
Palcza John,
Tseng Jack,
Canales Christina,
Egan Michael,
Kennedy Matthew,
Laterza Omar,
Ma Lei,
Scott Jack,
Tanen Michael,
Apter Jeffrey,
Backonja Miroslav,
Ereshefsky Larry,
Gevorkyan Hakop,
Jhee Stanford,
Rynders Rebecca,
Zari Arian,
Bryan Ellie,
Wagner John,
Troyer Matthew,
Stone Julie
Publication year - 2013
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2013.04.083
Subject(s) - placebo , medicine , pharmacokinetics , pharmacodynamics , pathogenesis , pharmacology , gastroenterology , urology , endocrinology , pathology , alternative medicine